A cost-effectiveness analysis of sensor-augmented insulin pump therapy and automated insulin suspension versus standard pump therapy for hypoglycemic unaware patients with type 1 diabetes. [electronic resource]
Producer: 20141008Description: 561-9 p. digitalISSN:- 1524-4733
- Australia
- Blood Glucose -- drug effects
- Blood Glucose Self-Monitoring -- methods
- Cost-Benefit Analysis
- Diabetes Mellitus, Type 1 -- drug therapy
- Humans
- Hypoglycemia -- chemically induced
- Hypoglycemic Agents -- administration & dosage
- Incidence
- Insulin -- administration & dosage
- Insulin Infusion Systems
- Quality of Life
- Quality-Adjusted Life Years
- Randomized Controlled Trials as Topic
- Severity of Illness Index
- Surveys and Questionnaires
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.